(-)-anisomycin multiple interactions EXP 6480464 [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [Anisomycin results in increased expression of ATF3 mRNA] CTD PMID:22003189 (-)-anisomycin increases expression EXP 6480464 Anisomycin results in increased expression of ATF3 mRNA CTD PMID:19101521 , PMID:22003189 (-)-citrinin increases expression EXP 6480464 Citrinin results in increased expression of ATF3 mRNA CTD PMID:21844328 (-)-demecolcine increases expression EXP 6480464 Demecolcine results in increased expression of ATF3 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ATF3 mRNA CTD PMID:22079256 (E)-cinnamyl alcohol increases expression EXP 6480464 cinnamyl alcohol results in increased expression of ATF3 mRNA CTD PMID:23999411 (S)-amphetamine increases expression ISO RGD:2165 6480464 Dextroamphetamine results in increased expression of ATF3 mRNA CTD PMID:18305237 (S)-nicotine increases expression ISO RGD:10198 6480464 Nicotine results in increased expression of ATF3 mRNA CTD PMID:17456735 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of ATF3 mRNA CTD PMID:24927667 1,1-dichloroethene increases expression ISO RGD:10198 6480464 vinylidene chloride results in increased expression of ATF3 mRNA CTD PMID:26682919 1,2,4-trimethylbenzene increases expression ISO RGD:2165 6480464 pseudocumene results in increased expression of ATF3 protein CTD PMID:17337753 1,3-benzothiazole-2-thiol increases expression EXP 6480464 captax results in increased expression of ATF3 mRNA CTD PMID:23999411 1,4-dithiothreitol increases expression EXP 6480464 Dithiothreitol results in increased expression of ATF3 mRNA CTD PMID:17332266 1,4-phenylenediamine increases expression EXP 6480464 4-phenylenediamine results in increased expression of ATF3 mRNA CTD PMID:16314067 more ... 1-(4-methoxybenzyl)-3-(5-nitro-1,3-thiazol-2-yl)urea multiple interactions EXP 6480464 N-(4-methoxybenzyl)-N'-(5-nitro-1, 3-thiazol-2-yl)urea inhibits the reaction [deoxynivalenol results in decreased degradation of ATF3 protein] CTD PMID:19101521 1-chloro-2,4-dinitrobenzene increases expression EXP 6480464 Dinitrochlorobenzene results in increased expression of ATF3 mRNA CTD PMID:23999411 more ... 1-chloro-2,4-dinitrobenzene multiple interactions EXP 6480464 KN 62 inhibits the reaction [Dinitrochlorobenzene results in increased expression of ATF3 mRNA] CTD PMID:27965148 1-fluoro-2,4-dinitrobenzene increases expression EXP 6480464 Dinitrofluorobenzene results in increased expression of ATF3 mRNA CTD PMID:23999411 1-naphthyl isothiocyanate increases expression ISO RGD:2165 6480464 1-Naphthylisothiocyanate results in increased expression of ATF3 mRNA CTD PMID:20551477 , PMID:25380136 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ATF3 mRNA, Ethinyl Estradiol results in increased expression of ATF3 protein CTD PMID:18001166 17alpha-ethynylestradiol increases expression ISO RGD:10198 6480464 Ethinyl Estradiol results in increased expression of ATF3 more ... CTD PMID:16569931 , PMID:18001166 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of ATF3 mRNA, Estradiol results in increased expression of ATF3 protein CTD PMID:16516039 more ... 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ATF3 mRNA CTD PMID:16474171 , PMID:19167446 17beta-estradiol affects expression ISO RGD:10198 6480464 Estradiol affects the expression of ATF3 mRNA CTD PMID:15598610 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression EXP 6480464 Metribolone results in increased expression of ATF3 protein CTD PMID:16516039 17beta-hydroxy-5alpha-androstan-3-one increases expression EXP 6480464 Dihydrotestosterone results in increased expression of ATF3 protein CTD PMID:16516039 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10198 6480464 Tetrachlorodibenzodioxin results in increased expression of ATF3 mRNA, Tetrachlorodibenzodioxin results in increased expression of ATF3 protein CTD PMID:16891777 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of ATF3 mRNA CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ATF3 mRNA CTD PMID:26238291 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10198 6480464 Tetrachlorodibenzodioxin affects the expression of ATF3 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2165 6480464 Tetrachlorodibenzodioxin results in increased expression of ATF3 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10198 6480464 Tetrachlorodibenzodioxin results in decreased expression of ATF3 mRNA CTD PMID:19770486 , PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10198 6480464 AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of ATF3 mRNA] CTD PMID:16891777 2,4-dinitrobenzenesulfonic acid increases expression ISO RGD:10198 6480464 2, 4-dinitrobenzenesulfonic acid results in increased expression of ATF3 mRNA CTD PMID:30116771 2,4-dinitrotoluene affects expression ISO RGD:2165 6480464 2, 4-dinitrotoluene affects the expression of ATF3 mRNA CTD PMID:21346803 2-amino-2-deoxy-D-glucopyranose decreases expression ISO RGD:10198 6480464 Glucosamine results in decreased expression of ATF3 mRNA CTD PMID:17178593 2-bromo-2-(bromomethyl)pentanedinitrile increases expression EXP 6480464 1 more ... CTD PMID:23999411 , PMID:27965148 2-butoxyethanol increases expression ISO RGD:10198 6480464 n-butoxyethanol results in increased expression of ATF3 mRNA CTD PMID:19812364 2-Ethylhexyl acrylate increases expression EXP 6480464 2-ethylhexyl acrylate results in increased expression of ATF3 mRNA CTD PMID:27965148 2-hydroxypropanoic acid increases expression EXP 6480464 Lactic Acid results in increased expression of ATF3 mRNA CTD PMID:30851411 2-nitrofluorene increases expression ISO RGD:2165 6480464 2-nitrofluorene results in increased expression of ATF3 mRNA CTD PMID:15890375 3,3',4',5-tetrachlorosalicylanilide increases expression EXP 6480464 3 more ... CTD PMID:27965148 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:2165 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:10198 6480464 tetrabromobisphenol A results in increased expression of ATF3 mRNA CTD PMID:25172293 3,3'-diindolylmethane increases expression EXP 6480464 3, 3'-diindolylmethane results in increased expression of ATF3 CTD PMID:15670751 3,4-dichloroaniline increases expression EXP 6480464 3, 4-dichloroaniline results in increased expression of ATF3 mRNA CTD PMID:24172598 3-phenylprop-2-enal increases expression EXP 6480464 cinnamic aldehyde results in increased expression of ATF3 mRNA CTD PMID:23999411 , PMID:27965148 4,4'-diaminodiphenylmethane increases expression ISO RGD:2165 6480464 4, 4'-diaminodiphenylmethane results in increased expression of ATF3 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol multiple interactions ISO RGD:10198 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of ATF3 mRNA CTD PMID:30951980 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression EXP 6480464 Oxazolone results in increased expression of ATF3 mRNA CTD PMID:23999411 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression ISO RGD:2165 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of ATF3 mRNA CTD PMID:15890375 4-hydroxynon-2-enal increases expression EXP 6480464 4-hydroxy-2-nonenal results in increased expression of ATF3 protein CTD PMID:19041636 4-hydroxyphenyl retinamide increases expression ISO RGD:10198 6480464 Fenretinide results in increased expression of ATF3 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of ATF3 mRNA CTD PMID:15958647 , PMID:16671099 4-hydroxyphenyl retinamide decreases response to substance EXP 6480464 ATF3 results in decreased susceptibility to Fenretinide CTD PMID:20022965 4-hydroxyphenyl retinamide affects expression EXP 6480464 Fenretinide affects the expression of ATF3 protein CTD PMID:20022965 4-hydroxyphenyl retinamide multiple interactions EXP 6480464 ATF3 mutant form promotes the reaction [Fenretinide results in increased expression of PMAIP1 mRNA], ATF3 mutant form promotes the reaction [Fenretinide results in increased expression of PMAIP1 protein] CTD PMID:20022965 4-nitrobenzyl bromide increases expression EXP 6480464 4-nitrobenzyl bromide results in increased expression of ATF3 mRNA CTD PMID:23999411 5-aza-2'-deoxycytidine affects expression EXP 6480464 Decitabine affects the expression of ATF3 mRNA CTD PMID:23300844 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of ATF3 mRNA CTD PMID:21856257 5-fluorouracil affects expression EXP 6480464 Fluorouracil affects the expression of ATF3 mRNA CTD PMID:15205334 5-fluorouracil multiple interactions EXP 6480464 TP53 protein affects the reaction [Fluorouracil results in increased expression of ATF3 mRNA] CTD PMID:15016801 5-fluorouracil increases expression EXP 6480464 Fluorouracil results in increased expression of ATF3 mRNA, Fluorouracil results in increased expression of ATF3 protein CTD PMID:14665630 more ... 6-propyl-2-thiouracil increases expression ISO RGD:2165 6480464 Propylthiouracil results in increased expression of ATF3 mRNA CTD PMID:24780913 abietic acid increases expression EXP 6480464 abietic acid results in increased expression of ATF3 mRNA CTD PMID:27965148 acrolein multiple interactions EXP 6480464 Acrolein results in increased expression of and affects the localization of ATF3 protein, Phenylbutyrates inhibits the reaction [Acrolein results in increased expression of ATF3 protein] CTD PMID:18951912 acrolein increases expression ISO RGD:2165 6480464 Acrolein results in increased expression of ATF3 mRNA, Acrolein results in increased expression of ATF3 protein CTD PMID:28119953 acrylamide decreases expression ISO RGD:2165 6480464 Acrylamide results in decreased expression of ATF3 mRNA CTD PMID:28959563 acrylamide increases expression ISO RGD:10198 6480464 Acrylamide results in increased expression of ATF3 mRNA CTD PMID:25531190 acrylamide multiple interactions ISO RGD:10198 6480464 Acetylcysteine inhibits the reaction [Acrylamide results in increased expression of and affects the localization of ATF3 protein] more ... CTD PMID:25531190 adefovir pivoxil increases expression EXP 6480464 adefovir dipivoxil results in increased expression of ATF3 mRNA CTD PMID:25596134 aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of ATF3 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ATF3 mRNA CTD PMID:21641981 more ... aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of ATF3 gene, Aflatoxin B1 results in increased methylation of ATF3 intron CTD PMID:27153756 , PMID:30157460 aflatoxin B1 increases expression ISO RGD:10198 6480464 Aflatoxin B1 results in increased expression of ATF3 mRNA CTD PMID:19770486 aflatoxin B1 increases expression ISO RGD:2165 6480464 Aflatoxin B1 results in increased expression of ATF3 mRNA CTD PMID:15890375 , PMID:25378103 aldehydo-D-glucosamine decreases expression ISO RGD:10198 6480464 Glucosamine results in decreased expression of ATF3 mRNA CTD PMID:17178593 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of ATF3 mRNA CTD PMID:23724009 all-trans-retinoic acid multiple interactions ISO RGD:10198 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of ATF3 mRNA more ... CTD PMID:30951980 Aloe emodin increases expression EXP 6480464 aloe emodin results in increased expression of ATF3 mRNA CTD PMID:22210228 alpha-hexylcinnamaldehyde increases expression EXP 6480464 hexyl cinnamic aldehyde results in increased expression of ATF3 mRNA CTD PMID:27965148 amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of ATF3 mRNA CTD PMID:19774075 amitriptyline increases expression ISO RGD:2165 6480464 Amitriptyline results in increased expression of ATF3 mRNA CTD PMID:22341215 ammonium chloride affects expression ISO RGD:2165 6480464 Ammonium Chloride affects the expression of ATF3 mRNA CTD PMID:16483693 amphetamine increases expression ISO RGD:2165 6480464 Amphetamine results in increased expression of ATF3 mRNA CTD PMID:30779732 amphibole asbestos increases expression EXP 6480464 Asbestos, Amphibole results in increased expression of ATF3 mRNA CTD PMID:20831825 aniline increases expression EXP 6480464 aniline analog results in increased expression of ATF3 mRNA CTD PMID:27965148 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:10198 6480464 pyrazolanthrone inhibits the reaction [Acrylamide results in increased expression of ATF3 protein] CTD PMID:25531190 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [O(2)-(2 more ... CTD PMID:22003962 antimycin A increases expression ISO RGD:10198 6480464 Antimycin A results in increased expression of ATF3 mRNA CTD PMID:19304788 antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of ATF3 mRNA CTD PMID:24449571 arachidonic acid increases expression EXP 6480464 Arachidonic Acid results in increased expression of ATF3 mRNA CTD PMID:16704987 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ATF3 mRNA alternative form CTD PMID:16934159 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of ATF3 mRNA alternative form CTD PMID:16934159 arsane decreases expression ISO RGD:10198 6480464 Arsenic results in decreased expression of ATF3 mRNA CTD PMID:19654921 arsenic atom decreases expression ISO RGD:10198 6480464 Arsenic results in decreased expression of ATF3 mRNA CTD PMID:19654921 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of ATF3 mRNA CTD PMID:20458559 arsenous acid decreases methylation EXP 6480464 Arsenic Trioxide results in decreased methylation of ATF3 promoter CTD PMID:26046465 asbestos increases expression EXP 6480464 Asbestos results in increased expression of ATF3 mRNA CTD PMID:22076105 benzene decreases expression EXP 6480464 Benzene results in decreased expression of ATF3 mRNA CTD PMID:20036648 benzene-1,2,4-triol increases expression EXP 6480464 hydroxyhydroquinone results in increased expression of ATF3 mRNA CTD PMID:24530881 benzene-1,2,4-triol multiple interactions EXP 6480464 4-aminobenzhydrazide inhibits the reaction [hydroxyhydroquinone results in increased expression of ATF3 mRNA] CTD PMID:24530881 benzo[a]pyrene increases expression ISO RGD:10198 6480464 Benzo(a)pyrene results in increased expression of ATF3 mRNA CTD PMID:21569818 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of ATF3 mRNA CTD PMID:20106945 more ... benzo[a]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 benzo[a]pyrene decreases expression ISO RGD:10198 6480464 Benzo(a)pyrene results in decreased expression of ATF3 mRNA CTD PMID:19770486 benzo[a]pyrene diol epoxide I increases expression EXP 6480464 7 more ... CTD PMID:19150397 more ... benzo[b]fluoranthene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of ATF3 mRNA CTD PMID:17690111 benzo[e]pyrene increases methylation EXP 6480464 benzo(e)pyrene results in increased methylation of ATF3 intron CTD PMID:30157460 benzyl benzoate increases expression EXP 6480464 benzyl benzoate results in increased expression of ATF3 mRNA CTD PMID:27965148 benzylpenicillin increases expression EXP 6480464 Penicillin G results in increased expression of ATF3 mRNA CTD PMID:27965148 beta-D-glucosamine decreases expression ISO RGD:10198 6480464 Glucosamine results in decreased expression of ATF3 mRNA CTD PMID:17178593 bicalutamide increases expression EXP 6480464 bicalutamide results in increased expression of ATF3 mRNA CTD PMID:15638997 bicalutamide decreases expression EXP 6480464 bicalutamide results in decreased expression of ATF3 protein CTD PMID:16516039 bilirubin IXalpha increases expression EXP 6480464 Bilirubin results in increased expression of ATF3 mRNA CTD PMID:20196124 bis(2-chloroethyl) sulfide affects expression ISO RGD:2165 6480464 Mustard Gas affects the expression of ATF3 mRNA CTD PMID:15651846 bis(2-chloroethyl) sulfide increases expression EXP 6480464 Mustard Gas results in increased expression of ATF3 mRNA CTD PMID:25102026 bis(2-chloroethyl) sulfide increases expression ISO RGD:10198 6480464 Mustard Gas results in increased expression of ATF3 mRNA CTD PMID:15674843 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:2165 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ATF3 promoter CTD PMID:23359474 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:10198 6480464 Diethylhexyl Phthalate results in decreased expression of ATF3 mRNA CTD PMID:28085963 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ATF3 mRNA CTD PMID:20170705 , PMID:30903817 bisphenol A decreases expression ISO RGD:10198 6480464 bisphenol A results in decreased expression of ATF3 mRNA CTD PMID:30951980 bisphenol A affects methylation ISO RGD:10198 6480464 bisphenol A affects the methylation of ATF3 promoter CTD PMID:27334623 bisphenol A affects expression ISO RGD:10198 6480464 bisphenol A affects the expression of ATF3 mRNA CTD PMID:25594700 bisphenol A increases expression ISO RGD:2165 6480464 bisphenol A results in increased expression of ATF3 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:10198 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of ATF3 mRNA more ... CTD PMID:27082013 , PMID:30951980 bisphenol A multiple interactions ISO RGD:2165 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ATF3 promoter CTD PMID:23359474 bisphenol A increases expression ISO RGD:10198 6480464 bisphenol A results in increased expression of ATF3 mRNA CTD PMID:12233820 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ATF3 mRNA CTD PMID:16474171 Bisphenol A diglycidyl ether increases expression EXP 6480464 2, 2-bis(4-glycidyloxyphenyl)propane results in increased expression of ATF3 mRNA CTD PMID:27965148 bisphenol F multiple interactions ISO RGD:10198 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of ATF3 mRNA CTD PMID:30951980 boron nitride increases expression EXP 6480464 boron nitride results in increased expression of ATF3 mRNA CTD PMID:30644070 bortezomib increases response to substance EXP 6480464 ATF3 results in increased susceptibility to Bortezomib CTD PMID:20022965 bortezomib increases expression ISO RGD:2165 6480464 Bortezomib results in increased expression of ATF3 mRNA, Bortezomib results in increased expression of ATF3 protein CTD PMID:20830808 bortezomib increases expression ISO RGD:10198 6480464 Bortezomib results in increased expression of ATF3 protein CTD PMID:20830808 bortezomib increases expression EXP 6480464 Bortezomib results in increased expression of ATF3 more ... CTD PMID:17898295 more ... bortezomib multiple interactions EXP 6480464 [BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in increased expression of ATF3 mRNA, ATF3 mutant form promotes the reaction [Bortezomib results in increased expression of PMAIP1 mRNA] CTD PMID:20022965 , PMID:25522274 bromocriptine increases expression EXP 6480464 Bromocriptine results in increased expression of ATF3 mRNA, Bromocriptine results in increased expression of ATF3 protein CTD PMID:21867702 butanal increases expression EXP 6480464 butyraldehyde results in increased expression of ATF3 mRNA CTD PMID:26079696 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of ATF3 mRNA CTD PMID:21172416 , PMID:21694771 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of ATF3 mRNA CTD PMID:24376830 cadmium dichloride increases expression ISO RGD:10198 6480464 Cadmium Chloride results in increased expression of ATF3 mRNA CTD PMID:20061341 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of ATF3 mRNA CTD PMID:25596134 , PMID:30796460 cadmium dichloride increases expression ISO RGD:2165 6480464 Cadmium Chloride results in increased expression of ATF3 mRNA CTD PMID:19010381 cadmium dichloride affects expression ISO RGD:2165 6480464 Cadmium Chloride affects the expression of ATF3 mRNA CTD PMID:22110744 cadmium sulfate increases expression EXP 6480464 cadmium sulfate results in increased expression of ATF3 mRNA CTD PMID:21783983 calcitriol decreases expression EXP 6480464 Calcitriol results in decreased expression of ATF3 mRNA CTD PMID:16002434 calcitriol multiple interactions EXP 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ATF3 mRNA CTD PMID:21592394 calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of ATF3 mRNA CTD PMID:21592394 cannabidiol increases expression ISO RGD:10198 6480464 Cannabidiol results in increased expression of ATF3 mRNA CTD PMID:21542829 capsaicin multiple interactions EXP 6480464 ATF3 mutant form inhibits the reaction [Capsaicin results in increased expression of GDF15 mRNA], Capsaicin promotes the reaction [CEBPB protein binds to ATF3 protein binds to GSK3B protein] CTD PMID:20110283 carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of ATF3 mRNA CTD PMID:25979313 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of ATF3 mRNA CTD PMID:22076105 , PMID:25511174 carbon nanotube decreases expression ISO RGD:10198 6480464 Nanotubes, Carbon results in decreased expression of ATF3 mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:10198 6480464 Nanotubes, Carbon analog results in increased expression of ATF3 mRNA, Nanotubes, Carbon results in increased expression of ATF3 mRNA CTD PMID:25554681 cefaloridine decreases expression ISO RGD:2165 6480464 Cephaloridine results in decreased expression of ATF3 mRNA CTD PMID:18500788 celastrol increases expression EXP 6480464 tripterine results in increased expression of ATF3 mRNA CTD PMID:17010675 chloroacetaldehyde increases expression EXP 6480464 chloroacetaldehyde results in increased expression of ATF3 mRNA CTD PMID:25596134 chloropicrin increases expression EXP 6480464 chloropicrin results in increased expression of ATF3 mRNA CTD PMID:26352163 chloroprene decreases expression ISO RGD:10198 6480464 Chloroprene results in decreased expression of ATF3 mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:10198 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATF3 mRNA CTD PMID:20938992 chromium(6+) increases expression EXP 6480464 chromium hexavalent ion results in increased expression of ATF3 mRNA CTD PMID:30690063 cidofovir anhydrous increases expression EXP 6480464 Cidofovir results in increased expression of ATF3 mRNA CTD PMID:25596134 cinnamyl alcohol increases expression EXP 6480464 cinnamyl alcohol results in increased expression of ATF3 mRNA CTD PMID:23999411 cisplatin multiple interactions EXP 6480464 Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ATF3 mRNA] more ... CTD PMID:21858171 , PMID:27392435 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of ATF3 mRNA CTD PMID:21532991 more ... cisplatin affects expression EXP 6480464 Cisplatin affects the expression of ATF3 mRNA CTD PMID:23300844 clodronic acid decreases expression EXP 6480464 Clodronic Acid results in decreased expression of ATF3 mRNA CTD PMID:25596134 clofibrate multiple interactions ISO RGD:10198 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ATF3 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ATF3 mRNA] CTD PMID:17585979 clotrimazole multiple interactions EXP 6480464 SB 203580 inhibits the reaction [Clotrimazole results in increased expression of ATF3 mRNA] CTD PMID:27507784 clotrimazole increases expression EXP 6480464 Clotrimazole results in increased expression of ATF3 mRNA CTD PMID:27507784 , PMID:27965148 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of ATF3 mRNA CTD PMID:19376846 , PMID:27965148 cobalt dichloride increases expression ISO RGD:2165 6480464 cobaltous chloride results in increased expression of ATF3 mRNA CTD PMID:24386269 cocaine decreases expression ISO RGD:2165 6480464 Cocaine results in decreased expression of ATF3 mRNA CTD PMID:27899881 cocaine increases expression ISO RGD:2165 6480464 Cocaine results in increased expression of ATF3 mRNA CTD PMID:23644055 copper atom increases expression EXP 6480464 Copper results in increased expression of ATF3 protein CTD PMID:20875833 copper atom multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in decreased expression of ATF3 mRNA, [NSC 689534 binds to Copper] which results in increased expression of ATF3 mRNA CTD PMID:20971185 , PMID:24690739 copper(0) increases expression EXP 6480464 Copper results in increased expression of ATF3 protein CTD PMID:20875833 copper(0) multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in decreased expression of ATF3 mRNA, [NSC 689534 binds to Copper] which results in increased expression of ATF3 mRNA CTD PMID:20971185 , PMID:24690739 copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of ATF3 mRNA CTD PMID:16283523 , PMID:19549813 coumestrol multiple interactions EXP 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATF3 mRNA CTD PMID:19167446 coumestrol decreases expression EXP 6480464 Coumestrol results in decreased expression of ATF3 mRNA CTD PMID:19167446 crocidolite asbestos increases expression EXP 6480464 Asbestos, Crocidolite results in increased expression of ATF3 mRNA CTD PMID:18687144 more ... crotonaldehyde increases expression EXP 6480464 2-butenal results in increased expression of ATF3 mRNA CTD PMID:20471460 CU-O LINKAGE increases expression EXP 6480464 cupric oxide results in increased expression of ATF3 mRNA CTD PMID:22077320 curcumin increases expression EXP 6480464 Curcumin results in increased expression of ATF3 mRNA, Curcumin results in increased expression of ATF3 protein CTD PMID:15713895 more ... cycloheximide multiple interactions ISO RGD:10198 6480464 Cycloheximide inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of ATF3 protein] CTD PMID:23593480 cyclosporin A increases expression ISO RGD:10198 6480464 Cyclosporine results in increased expression of ATF3 mRNA CTD PMID:23958496 , PMID:27585667 cyclosporin A multiple interactions ISO RGD:10198 6480464 ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Cyclosporine results in increased expression of ATF3 mRNA], TLR4 gene mutant form inhibits the reaction [Cyclosporine results in increased expression of ATF3 mRNA] CTD PMID:27585667 cyclosporin A increases expression ISO RGD:2165 6480464 Cyclosporine results in increased expression of ATF3 mRNA CTD PMID:25596134 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of ATF3 mRNA, Cyclosporine results in increased expression of ATF3 protein CTD PMID:19159671 more ... cylindrospermopsin increases expression EXP 6480464 cylindrospermopsin results in increased expression of ATF3 mRNA CTD PMID:24921660 , PMID:30500929 cytarabine decreases expression EXP 6480464 Cytarabine results in decreased expression of ATF3 mRNA CTD PMID:21198554 DDE increases activity EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased activity of ATF3 protein CTD PMID:27589886 DDT increases expression ISO RGD:2165 6480464 DDT results in increased expression of ATF3 mRNA CTD PMID:30207508 deoxynivalenol multiple interactions EXP 6480464 [[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which affects the localization of ELAVL1 protein] which co-treated with deoxynivalenol] promotes the reaction [[ELAVL1 protein binds to ATF3 3' UTR] which results in increased stability of ATF3 mRNA] more ... CTD PMID:19101521 more ... deoxynivalenol decreases expression ISO RGD:10198 6480464 deoxynivalenol results in decreased expression of ATF3 mRNA CTD PMID:23253260 deoxynivalenol increases expression ISO RGD:10198 6480464 deoxynivalenol results in increased expression of ATF3 mRNA CTD PMID:21074547 deoxynivalenol increases expression EXP 6480464 deoxynivalenol results in increased expression of ATF3 mRNA more ... CTD PMID:19101521 more ... deoxynivalenol increases response to substance EXP 6480464 ATF3 protein results in increased susceptibility to deoxynivalenol CTD PMID:19101521 deoxynivalenol decreases degradation EXP 6480464 deoxynivalenol results in decreased degradation of ATF3 mRNA, deoxynivalenol results in decreased degradation of ATF3 protein CTD PMID:19101521 dexamethasone decreases expression ISO RGD:10198 6480464 Dexamethasone results in decreased expression of ATF3 mRNA CTD PMID:22733784 diallyl disulfide increases expression EXP 6480464 diallyl disulfide results in increased expression of ATF3 protein CTD PMID:15897233 diarsenic trioxide decreases methylation EXP 6480464 Arsenic Trioxide results in decreased methylation of ATF3 promoter CTD PMID:26046465 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of ATF3 mRNA CTD PMID:20458559 dibenz[a,h]anthracene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 dibenzo[a,l]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with dibenzo(a, l)pyrene] results in increased expression of ATF3 mRNA CTD PMID:17690111 dibutyl phthalate increases expression ISO RGD:10198 6480464 Dibutyl Phthalate results in increased expression of ATF3 mRNA CTD PMID:21266533 dibutyl phthalate multiple interactions ISO RGD:2165 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ATF3 promoter CTD PMID:23359474 dibutyl phthalate increases expression ISO RGD:2165 6480464 Dibutyl Phthalate results in increased expression of ATF3 mRNA CTD PMID:21266533 dichloroacetic acid increases expression ISO RGD:10198 6480464 Dichloroacetic Acid results in increased expression of ATF3 mRNA CTD PMID:28962523 diethylenetriamine increases expression EXP 6480464 diethylenetriamine results in increased expression of ATF3 mRNA CTD PMID:27965148 diethylstilbestrol increases expression ISO RGD:2165 6480464 Diethylstilbestrol results in increased expression of ATF3 mRNA CTD PMID:15890375 , PMID:21658437 dimethyl sulfoxide increases expression ISO RGD:2165 6480464 Dimethyl Sulfoxide results in increased expression of ATF3 mRNA CTD PMID:22193206 Dinophysistoxin 1 increases expression EXP 6480464 dinophysistoxin 1 results in increased expression of ATF3 mRNA CTD PMID:28939011 dioxygen affects expression ISO RGD:10198 6480464 Oxygen deficiency affects the expression of ATF3 mRNA CTD PMID:17193925 dioxygen multiple interactions ISO RGD:10198 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATF3 mRNA CTD PMID:30529165 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of ATF3 mRNA CTD PMID:20042640 , PMID:25596134 diquat increases expression EXP 6480464 Diquat results in increased expression of ATF3 mRNA CTD PMID:21172416 disulfiram multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in decreased expression of ATF3 mRNA CTD PMID:24690739 diuron decreases expression EXP 6480464 Diuron metabolite results in decreased expression of ATF3 mRNA CTD PMID:24172598 dodecan-1-ol increases expression EXP 6480464 Dodecanol analog results in increased expression of ATF3 mRNA CTD PMID:27965148 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression EXP 6480464 Doxorubicin affects the expression of ATF3 mRNA CTD PMID:15205334 doxorubicin decreases expression ISO RGD:2165 6480464 Doxorubicin results in decreased expression of ATF3 mRNA CTD PMID:30261314 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of ATF3 mRNA CTD PMID:29803840 doxorubicin decreases expression ISO RGD:10198 6480464 Doxorubicin results in decreased expression of ATF3 mRNA CTD PMID:15033991 echinacoside multiple interactions EXP 6480464 echinacoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of ATF3] CTD PMID:27432061 ellagic acid increases expression EXP 6480464 Ellagic Acid results in increased expression of ATF3 mRNA CTD PMID:12002526 endosulfan increases expression ISO RGD:2165 6480464 Endosulfan results in increased expression of ATF3 mRNA CTD PMID:29391264 Enterolactone multiple interactions EXP 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATF3 mRNA CTD PMID:19167446 ethanol multiple interactions ISO RGD:10198 6480464 Hydralazine inhibits the reaction [Ethanol results in increased expression of ATF3 mRNA] CTD PMID:28119953 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of ATF3 mRNA CTD PMID:31059573 ethanol increases expression ISO RGD:2165 6480464 Ethanol results in increased expression of ATF3 mRNA, Ethanol results in increased expression of ATF3 protein CTD PMID:28119953 ethanol increases expression ISO RGD:10198 6480464 Ethanol results in increased expression of ATF3 mRNA, Ethanol results in increased expression of ATF3 protein CTD PMID:28119953 ethyl methanesulfonate increases expression EXP 6480464 Ethyl Methanesulfonate results in increased expression of ATF3 mRNA CTD PMID:23649840 ethylene glycol dimethacrylate increases expression EXP 6480464 ethylene dimethacrylate results in increased expression of ATF3 mRNA CTD PMID:27965148 ethylenediamine increases expression EXP 6480464 ethylenediamine results in increased expression of ATF3 mRNA CTD PMID:27965148 eugenol increases expression EXP 6480464 Eugenol results in increased expression of ATF3 mRNA CTD PMID:23999411 farnesol increases expression EXP 6480464 Farnesol results in increased expression of ATF3 mRNA CTD PMID:27965148 fenamidone increases expression ISO RGD:10198 6480464 fenamidone results in increased expression of ATF3 mRNA CTD PMID:27029645 fenofibrate multiple interactions ISO RGD:10198 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of ATF3 mRNA CTD PMID:18978307 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of ATF3 mRNA CTD PMID:25596134 fenofibrate increases expression ISO RGD:2165 6480464 Fenofibrate results in increased expression of ATF3 mRNA CTD PMID:25596134 ferric oxide increases expression ISO RGD:10198 6480464 ferric oxide analog results in increased expression of ATF3 protein CTD PMID:24068039 fluoranthene multiple interactions ISO RGD:10198 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of ATF3 mRNA CTD PMID:28329830 flutamide increases expression ISO RGD:10198 6480464 Flutamide analog results in increased expression of ATF3 mRNA, Flutamide results in increased expression of ATF3 mRNA CTD PMID:17702527 folic acid multiple interactions ISO RGD:10198 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATF3 mRNA CTD PMID:20938992 folic acid multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of ATF3 mRNA CTD PMID:24657277 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of ATF3 mRNA CTD PMID:20655997 more ... furan increases expression ISO RGD:10198 6480464 furan results in increased expression of ATF3 mRNA CTD PMID:24183702 gedunin increases expression EXP 6480464 gedunin results in increased expression of ATF3 mRNA CTD PMID:17010675 gemcitabine increases expression EXP 6480464 gemcitabine results in increased expression of ATF3 mRNA CTD PMID:17039268 genistein decreases expression EXP 6480464 Genistein results in decreased expression of ATF3 mRNA CTD PMID:16474171 , PMID:20884965 genistein increases expression EXP 6480464 Genistein results in increased expression of ATF3 mRNA, Genistein results in increased expression of ATF3 protein CTD PMID:21554132 , PMID:26865667 gentamycin increases expression ISO RGD:2165 6480464 Gentamicins results in increased expression of ATF3 mRNA CTD PMID:22061828 geraniol increases expression EXP 6480464 geraniol results in increased expression of ATF3 mRNA CTD PMID:27683099 glycidol decreases expression ISO RGD:2165 6480464 glycidol results in decreased expression of ATF3 mRNA CTD PMID:24915197 glyoxal increases expression EXP 6480464 Glyoxal results in increased expression of ATF3 mRNA CTD PMID:23999411 , PMID:27965148 graphite affects expression ISO RGD:2165 6480464 Graphite affects the expression of ATF3 mRNA CTD PMID:29933104 hydralazine multiple interactions ISO RGD:10198 6480464 Hydralazine inhibits the reaction [Ethanol results in increased expression of ATF3 mRNA] CTD PMID:28119953 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of ATF3, Hydrogen Peroxide results in increased expression of ATF3 mRNA CTD PMID:12414654 , PMID:18687144 hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of ATF3 mRNA CTD PMID:20044591 hydroquinone increases expression EXP 6480464 hydroquinone results in increased expression of ATF3 mRNA CTD PMID:31256213 imidurea increases expression EXP 6480464 imidazolidinyl urea results in increased expression of ATF3 mRNA CTD PMID:27965148 indole-3-methanol affects expression ISO RGD:2165 6480464 indole-3-carbinol affects the expression of ATF3 mRNA CTD PMID:21396975 irinotecan increases expression EXP 6480464 Irinotecan metabolite results in increased expression of ATF3 mRNA, Irinotecan results in increased expression of ATF3 mRNA CTD PMID:15956246 isoeugenol increases expression EXP 6480464 isoeugenol results in increased expression of ATF3 mRNA CTD PMID:23999411 isoprenaline increases expression ISO RGD:2165 6480464 Isoproterenol results in increased expression of ATF3 protein CTD PMID:25136830 isoprenaline increases expression ISO RGD:10198 6480464 Isoproterenol results in increased expression of ATF3 mRNA CTD PMID:21823215 isoprenaline multiple interactions ISO RGD:2165 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Isoproterenol results in increased expression of ATF3 protein] CTD PMID:25136830 L-1,4-dithiothreitol increases expression EXP 6480464 Dithiothreitol results in increased expression of ATF3 mRNA CTD PMID:17332266 L-ascorbic acid multiple interactions EXP 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of ATF3 mRNA CTD PMID:17639512 L-methionine multiple interactions ISO RGD:10198 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATF3 mRNA CTD PMID:20938992 lamivudine multiple interactions EXP 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of ATF3 mRNA CTD PMID:15784690 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of ATF3 mRNA CTD PMID:28988120 limonene increases expression EXP 6480464 limonene results in increased expression of ATF3 mRNA CTD PMID:27965148 lipopolysaccharide multiple interactions ISO RGD:2165 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of ATF3 mRNA, Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of ATF3 mRNA] CTD PMID:16401727 , PMID:16415329 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of ATF3 mRNA CTD PMID:27783115 lipopolysaccharide increases expression ISO RGD:2165 6480464 Lipopolysaccharides results in increased expression of ATF3 mRNA CTD PMID:16415329 menadione affects expression EXP 6480464 Vitamin K 3 affects the expression of ATF3 mRNA CTD PMID:20044591 menadione increases expression EXP 6480464 Vitamin K 3 results in increased expression of ATF3 mRNA CTD PMID:12414654 mercury dibromide multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATF3 mRNA CTD PMID:27188386 mercury dichloride increases expression ISO RGD:2165 6480464 Mercuric Chloride results in increased expression of ATF3 mRNA, Mercuric Chloride results in increased expression of ATF3 protein CTD PMID:16507785 metacetamol decreases expression ISO RGD:10198 6480464 3-hydroxyacetanilide results in decreased expression of ATF3 mRNA CTD PMID:18544908 metformin increases expression ISO RGD:2165 6480464 Metformin results in increased expression of ATF3 mRNA CTD PMID:25596134 methamphetamine multiple interactions ISO RGD:2165 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of ATF3 mRNA, SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of ATF3 mRNA] CTD PMID:19564919 methamphetamine increases expression ISO RGD:2165 6480464 Methamphetamine results in increased expression of ATF3 mRNA, Methamphetamine results in increased expression of ATF3 protein CTD PMID:19564919 methapyrilene increases methylation EXP 6480464 Methapyrilene results in increased methylation of ATF3 intron CTD PMID:30157460 methapyrilene increases expression ISO RGD:2165 6480464 Methapyrilene results in increased expression of ATF3 mRNA CTD PMID:15890375 , PMID:22484513 methotrexate affects expression ISO RGD:10198 6480464 Methotrexate affects the expression of ATF3 mRNA CTD PMID:18502557 methotrexate multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of ATF3 mRNA CTD PMID:24657277 methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of ATF3 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:10198 6480464 methylmercuric chloride results in increased expression of ATF3 mRNA CTD PMID:20061341 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of ATF3 mRNA CTD PMID:26272509 , PMID:28001369 methylseleninic acid affects expression EXP 6480464 methylselenic acid affects the expression of ATF3 mRNA CTD PMID:14617803 mifepristone multiple interactions EXP 6480464 Mifepristone inhibits the reaction [Progesterone results in increased expression of ATF3 mRNA] CTD PMID:15674352 minocycline multiple interactions ISO RGD:2165 6480464 Minocycline inhibits the reaction [Paclitaxel results in increased expression of ATF3 protein] CTD PMID:21050491 mono(2-ethylhexyl) phthalate increases expression ISO RGD:2165 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of ATF3 mRNA CTD PMID:16809437 motexafin gadolinium multiple interactions EXP 6480464 motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of ATF3 mRNA] CTD PMID:16357179 motexafin gadolinium increases expression EXP 6480464 motexafin gadolinium results in increased expression of ATF3 mRNA CTD PMID:16357179 muramyl dipeptide multiple interactions EXP 6480464 [[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which affects the localization of ELAVL1 protein] which co-treated with deoxynivalenol] promotes the reaction [[ELAVL1 protein binds to ATF3 3' UTR] which results in increased stability of ATF3 mRNA] more ... CTD PMID:22003189 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO RGD:2165 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Isoproterenol results in increased expression of ATF3 protein] CTD PMID:25136830 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Dinoprostone results in increased expression of ATF3 protein] CTD PMID:30409902 N-acetyl-L-cysteine multiple interactions ISO RGD:10198 6480464 Acetylcysteine inhibits the reaction [Acrylamide results in increased expression of and affects the localization of ATF3 protein] CTD PMID:25531190 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:10198 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of ATF3 protein CTD PMID:23593480 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:10198 6480464 Cycloheximide inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of ATF3 protein] CTD PMID:23593480 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of ATF3, 1-Methyl-4-phenylpyridinium results in increased expression of ATF3 mRNA CTD PMID:24810058 , PMID:27432061 N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 echinacoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of ATF3] CTD PMID:27432061 N-nitrosodiethylamine affects expression ISO RGD:10198 6480464 Diethylnitrosamine affects the expression of ATF3 mRNA, Diethylnitrosamine affects the expression of ATF3 protein CTD PMID:21159647 N-nitrosodiethylamine multiple interactions ISO RGD:10198 6480464 [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of ATF3 mRNA, [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of ATF3 mRNA CTD PMID:18978307 , PMID:19690152 N-nitrosodimethylamine increases expression ISO RGD:2165 6480464 Dimethylnitrosamine results in increased expression of ATF3 mRNA CTD PMID:15890375 , PMID:25380136 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions ISO RGD:2165 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of ATF3 mRNA, Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of ATF3 mRNA] CTD PMID:16401727 , PMID:16415329 naphthalene increases expression ISO RGD:10198 6480464 naphthalene results in increased expression of ATF3 mRNA CTD PMID:18978301 naphthalenes increases expression ISO RGD:2165 6480464 Naphthalenes results in increased expression of ATF3 protein CTD PMID:17337753 nelfinavir increases expression EXP 6480464 Nelfinavir results in increased expression of ATF3, Nelfinavir results in increased expression of ATF3 mRNA CTD PMID:21762082 , PMID:22935518 nickel atom increases expression EXP 6480464 Nickel results in increased expression of ATF3 mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride increases expression EXP 6480464 nickel chloride results in increased expression of ATF3 mRNA CTD PMID:17312168 nickel dichloride affects expression ISO RGD:2165 6480464 nickel chloride affects the expression of ATF3 mRNA CTD PMID:22110744 nickel subsulfide affects expression ISO RGD:10198 6480464 nickel subsulfide affects the expression of ATF3 mRNA CTD PMID:12729255 nickel subsulfide increases expression ISO RGD:2165 6480464 nickel subsulfide results in increased expression of ATF3 mRNA CTD PMID:24952340 nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of ATF3 mRNA CTD PMID:16314067 Niclosamide multiple interactions EXP 6480464 ATF3 protein affects the reaction [Niclosamide results in increased cleavage of CASP3 protein] more ... CTD PMID:26917416 Niclosamide increases expression EXP 6480464 Niclosamide results in increased expression of ATF3 mRNA, Niclosamide results in increased expression of ATF3 protein CTD PMID:26917416 nicotine increases expression EXP 6480464 Nicotine results in increased expression of ATF3 mRNA CTD PMID:24927667 nicotine increases expression ISO RGD:10198 6480464 Nicotine results in increased expression of ATF3 mRNA CTD PMID:17456735 Nivalenol increases expression EXP 6480464 nivalenol results in increased expression of ATF3 mRNA CTD PMID:19101521 nonivamide increases expression EXP 6480464 nonivamide results in increased expression of ATF3 mRNA CTD PMID:17332266 nonivamide multiple interactions EXP 6480464 [nonivamide binds to and results in increased activity of TRPV1 protein] which results in increased expression of ATF3 mRNA CTD PMID:17332266 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of ATF3 mRNA CTD PMID:30559759 octanoic acid increases expression EXP 6480464 octanoic acid results in increased expression of ATF3 mRNA CTD PMID:27965148 orphenadrine affects expression ISO RGD:2165 6480464 Orphenadrine affects the expression of ATF3 mRNA CTD PMID:23665939 oxaliplatin increases expression ISO RGD:2165 6480464 oxaliplatin results in increased expression of ATF3 mRNA CTD PMID:25729387 oxaliplatin multiple interactions ISO RGD:2165 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ATF3 mRNA CTD PMID:25729387 ozone increases expression ISO RGD:10198 6480464 Ozone results in increased expression of ATF3 mRNA CTD PMID:19555225 ozone increases expression ISO RGD:2165 6480464 Ozone results in increased expression of ATF3 mRNA CTD PMID:16716893 p-chloromercuribenzoic acid multiple interactions EXP 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATF3 mRNA CTD PMID:27188386 paclitaxel multiple interactions ISO RGD:2165 6480464 Minocycline inhibits the reaction [Paclitaxel results in increased expression of ATF3 protein] CTD PMID:21050491 paclitaxel increases expression ISO RGD:2165 6480464 Paclitaxel results in increased expression of ATF3 protein CTD PMID:16854522 more ... panobinostat increases expression EXP 6480464 panobinostat results in increased expression of ATF3 mRNA CTD PMID:26272509 paracetamol multiple interactions ISO RGD:10198 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ATF3 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ATF3 mRNA] CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ATF3 mRNA CTD PMID:21420995 , PMID:29067470 paracetamol affects expression ISO RGD:10198 6480464 Acetaminophen affects the expression of ATF3 mRNA CTD PMID:15606129 , PMID:17562736 paracetamol increases expression ISO RGD:10198 6480464 Acetaminophen results in increased expression of ATF3 mRNA CTD PMID:11264010 more ... paraquat increases expression ISO RGD:10198 6480464 Paraquat results in increased expression of ATF3 mRNA CTD PMID:12595580 patulin increases expression EXP 6480464 Patulin results in increased expression of ATF3 mRNA CTD PMID:21844328 pentachlorophenol increases expression EXP 6480464 Pentachlorophenol results in increased expression of ATF3 mRNA CTD PMID:27965148 pentanal increases expression EXP 6480464 pentanal results in increased expression of ATF3 mRNA CTD PMID:26079696 perfluorodecanoic acid increases expression EXP 6480464 perfluorodecanoic acid results in increased expression of ATF3 mRNA CTD PMID:23567314 perfluorododecanoic acid increases expression EXP 6480464 perfluorododecanoic acid results in increased expression of ATF3 mRNA CTD PMID:23567314 perfluorododecanoic acid increases expression ISO RGD:10198 6480464 perfluorododecanoic acid results in increased expression of ATF3 mRNA CTD PMID:23567314 perfluorooctanoic acid increases expression ISO RGD:2165 6480464 perfluorooctanoic acid results in increased expression of ATF3 mRNA CTD PMID:19162173 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of ATF3 mRNA CTD PMID:25868421 perfluoroundecanoic acid increases expression ISO RGD:10198 6480464 perfluoro-n-undecanoic acid results in increased expression of ATF3 mRNA CTD PMID:23567314 phenobarbital multiple interactions ISO RGD:10198 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ATF3 mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:10198 6480464 Phenobarbital affects the expression of ATF3 mRNA CTD PMID:23091169 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of ATF3 mRNA CTD PMID:19159669 phenobarbital increases expression ISO RGD:10198 6480464 Phenobarbital results in increased expression of ATF3 mRNA CTD PMID:19482888 phenobarbital decreases expression ISO RGD:10198 6480464 Phenobarbital results in decreased expression of ATF3 mRNA CTD PMID:19270015 phenyl benzoate increases expression EXP 6480464 diphenylcarboxylate results in increased expression of ATF3 mRNA CTD PMID:27965148 phenylmercury acetate increases expression EXP 6480464 Phenylmercuric Acetate results in increased expression of ATF3 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATF3 mRNA CTD PMID:27188386 phlorizin decreases expression ISO RGD:10198 6480464 Phlorhizin results in decreased expression of ATF3 mRNA CTD PMID:16123366 phosgene affects expression ISO RGD:10198 6480464 Phosgene affects the expression of ATF3 mRNA CTD PMID:16300373 pioglitazone multiple interactions EXP 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ATF3 mRNA CTD PMID:20847119 piperonyl butoxide multiple interactions ISO RGD:10198 6480464 [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of ATF3 mRNA CTD PMID:19690152 piperonyl butoxide increases expression ISO RGD:2165 6480464 Piperonyl Butoxide results in increased expression of ATF3 mRNA CTD PMID:15890375 piperonyl butoxide increases expression ISO RGD:10198 6480464 Piperonyl Butoxide results in increased expression of ATF3 mRNA CTD PMID:19690152 pirinixic acid decreases expression ISO RGD:10198 6480464 pirinixic acid results in decreased expression of ATF3 mRNA CTD PMID:17426115 pirinixic acid increases expression ISO RGD:10198 6480464 pirinixic acid results in increased expression of ATF3 mRNA CTD PMID:18445702 , PMID:23811191 pirinixic acid increases expression ISO RGD:2165 6480464 pirinixic acid results in increased expression of ATF3 mRNA CTD PMID:15890375 piroxicam decreases expression EXP 6480464 Piroxicam results in decreased expression of ATF3 mRNA CTD PMID:21858171 piroxicam multiple interactions EXP 6480464 Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ATF3 mRNA] CTD PMID:21858171 poly(I:C) increases expression EXP 6480464 Poly I-C results in increased expression of ATF3 mRNA CTD PMID:27783115 potassium bromate increases expression ISO RGD:2165 6480464 potassium bromate results in increased expression of ATF3 mRNA CTD PMID:23588252 potassium bromate multiple interactions ISO RGD:10198 6480464 [potassium bromate co-treated with bisphenol A] affects the expression of ATF3 mRNA, [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of ATF3 mRNA] CTD PMID:27082013 potassium chromate increases expression EXP 6480464 potassium chromate(VI) results in increased expression of ATF3 mRNA CTD PMID:22079256 potassium chromate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ATF3 mRNA CTD PMID:22079256 potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of ATF3 mRNA CTD PMID:11678601 pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:10198 6480464 NR1I2 protein promotes the reaction [Pregnenolone Carbonitrile results in decreased expression of ATF3 mRNA] CTD PMID:22698814 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:10198 6480464 Pregnenolone Carbonitrile results in decreased expression of ATF3 mRNA CTD PMID:22698814 progesterone multiple interactions EXP 6480464 Mifepristone inhibits the reaction [Progesterone results in increased expression of ATF3 mRNA] CTD PMID:15674352 progesterone increases expression EXP 6480464 Progesterone results in increased expression of ATF3 mRNA CTD PMID:15674352 propiconazole increases expression ISO RGD:10198 6480464 propiconazole results in increased expression of ATF3 mRNA CTD PMID:21278054 prostaglandin E2 increases expression EXP 6480464 Dinoprostone results in increased expression of ATF3 protein CTD PMID:30409902 prostaglandin E2 multiple interactions EXP 6480464 ATF3 protein affects the reaction [Dinoprostone results in decreased expression of SIRT1 mRNA] more ... CTD PMID:30409902 pyrazinecarboxamide increases expression ISO RGD:2165 6480464 Pyrazinamide results in increased expression of ATF3 mRNA CTD PMID:22431067 quartz increases expression EXP 6480464 Quartz results in increased expression of ATF3 mRNA CTD PMID:29102675 quartz multiple interactions EXP 6480464 ATF3 protein affects the reaction [Quartz results in increased secretion of IL1B protein] more ... CTD PMID:29102675 quercetin multiple interactions EXP 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of ATF3 mRNA CTD PMID:17639512 quercetin increases expression EXP 6480464 Quercetin results in increased expression of ATF3 mRNA CTD PMID:21632981 rac-lactic acid increases expression EXP 6480464 Lactic Acid results in increased expression of ATF3 mRNA CTD PMID:30851411 raloxifene multiple interactions EXP 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of ATF3 mRNA CTD PMID:19059307 raloxifene increases expression EXP 6480464 Raloxifene Hydrochloride results in increased expression of ATF3 mRNA CTD PMID:16497877 ranitidine multiple interactions ISO RGD:2165 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of ATF3 mRNA, Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of ATF3 mRNA] CTD PMID:16401727 , PMID:16415329 reactive oxygen species increases expression EXP 6480464 Reactive Oxygen Species results in increased expression of ATF3 mRNA CTD PMID:25800948 resorcinol increases expression EXP 6480464 resorcinol results in increased expression of ATF3 mRNA CTD PMID:27965148 resveratrol multiple interactions EXP 6480464 ATF3 protein affects the reaction [Resveratrol results in increased expression of KL mRNA] more ... CTD PMID:21205742 , PMID:24911970 resveratrol affects response to substance ISO RGD:2165 6480464 ATF3 protein affects the susceptibility to resveratrol CTD PMID:24911970 resveratrol multiple interactions ISO RGD:2165 6480464 ATF3 protein affects the reaction [resveratrol results in increased expression of KL mRNA] more ... CTD PMID:24911970 resveratrol affects response to substance EXP 6480464 ATF3 protein affects the susceptibility to resveratrol CTD PMID:24911970 resveratrol increases expression EXP 6480464 Resveratrol results in increased expression of ATF3 mRNA, Resveratrol results in increased expression of ATF3 protein CTD PMID:12002526 more ... resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of ATF3 mRNA CTD PMID:19167446 rotenone multiple interactions ISO RGD:10198 6480464 DDIT3 protein affects the reaction [Rotenone results in increased expression of ATF3 mRNA] CTD PMID:19304788 rotenone decreases expression ISO RGD:2165 6480464 Rotenone results in decreased expression of ATF3 mRNA CTD PMID:28374803 rotenone increases expression ISO RGD:10198 6480464 Rotenone results in increased expression of ATF3 mRNA CTD PMID:17702527 more ... S-adenosyl-L-methioninate increases expression ISO RGD:10198 6480464 S-Adenosylmethionine results in increased expression of ATF3 mRNA CTD PMID:18098314 S-adenosyl-L-methionine increases expression ISO RGD:10198 6480464 S-Adenosylmethionine results in increased expression of ATF3 mRNA CTD PMID:18098314 Salinomycin increases expression EXP 6480464 salinomycin results in increased expression of ATF3 mRNA CTD PMID:22215106 salubrinal increases expression EXP 6480464 salubrinal results in increased expression of ATF3 mRNA CTD PMID:23690448 SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [Clotrimazole results in increased expression of ATF3 mRNA] more ... CTD PMID:19101521 , PMID:27507784 SB 203580 multiple interactions ISO RGD:10198 6480464 SB 203580 inhibits the reaction [Acrylamide results in increased expression of ATF3 protein] CTD PMID:25531190 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SC-58125 increases expression EXP 6480464 1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole results in increased expression of ATF3 mRNA, 1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole results in increased expression of ATF3 protein CTD PMID:14633654 , PMID:15897233 SCH 23390 multiple interactions ISO RGD:2165 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of ATF3 mRNA, SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of ATF3 mRNA] CTD PMID:19564919 SCH 23390 decreases expression ISO RGD:2165 6480464 SCH 23390 results in decreased expression of ATF3 mRNA CTD PMID:19564919 serpentine asbestos increases expression EXP 6480464 Asbestos, Serpentine results in increased expression of ATF3 mRNA CTD PMID:18197826 Shikonin multiple interactions ISO RGD:10198 6480464 shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of ATF3 mRNA] CTD PMID:25451590 silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of ATF3 mRNA, Silicon Dioxide results in increased expression of ATF3 mRNA CTD PMID:22300531 more ... silicon dioxide increases expression ISO RGD:10198 6480464 Silicon Dioxide results in increased expression of ATF3 mRNA CTD PMID:19073995 silver atom increases expression EXP 6480464 Silver results in increased expression of ATF3 mRNA CTD PMID:26014281 , PMID:28959546 silver(0) increases expression EXP 6480464 Silver results in increased expression of ATF3 mRNA CTD PMID:26014281 , PMID:28959546 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of ATF3 mRNA CTD PMID:17428261 sirolimus multiple interactions EXP 6480464 [(+)-JQ1 compound co-treated with Sirolimus] affects the expression of ATF3 mRNA CTD PMID:25307878 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of ATF3 mRNA CTD PMID:28595984 sodium arsenite multiple interactions EXP 6480464 CAT protein inhibits the reaction [sodium arsenite results in increased expression of ATF3 mRNA] more ... CTD PMID:26148435 sodium arsenite increases expression ISO RGD:10198 6480464 sodium arsenite results in increased expression of ATF3 mRNA, sodium arsenite results in increased expression of ATF3 protein CTD PMID:16014739 , PMID:17003472 sodium arsenite increases expression ISO RGD:2165 6480464 sodium arsenite results in increased expression of ATF3 protein CTD PMID:26432159 sodium arsenite multiple interactions ISO RGD:10198 6480464 IFNG protein inhibits the reaction [sodium arsenite results in increased expression of ATF3 protein] CTD PMID:17003472 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of ATF3 mRNA, sodium arsenite results in increased expression of ATF3 protein CTD PMID:12760830 more ... sodium arsenite increases activity EXP 6480464 sodium arsenite results in increased activity of ATF3 protein CTD PMID:12220541 sodium dichromate affects expression ISO RGD:2165 6480464 sodium bichromate affects the expression of ATF3 mRNA CTD PMID:22110744 sodium dichromate increases expression ISO RGD:2165 6480464 sodium bichromate results in increased expression of ATF3 mRNA CTD PMID:22561333 , PMID:25993096 sodium dichromate increases expression ISO RGD:10198 6480464 sodium bichromate results in increased expression of ATF3 mRNA CTD PMID:27859739 sodium dodecyl sulfate increases expression EXP 6480464 Sodium Dodecyl Sulfate results in increased expression of ATF3 mRNA CTD PMID:23999411 Soman increases expression ISO RGD:2165 6480464 Soman results in increased expression of ATF3 mRNA CTD PMID:19281266 styrene affects expression ISO RGD:10198 6480464 Styrene affects the expression of ATF3 mRNA CTD PMID:28951217 sulindac increases expression EXP 6480464 Sulindac results in increased expression of ATF3 mRNA CTD PMID:11906190 sulindac sulfide increases expression EXP 6480464 sulindac sulfide results in increased expression of ATF3 mRNA, sulindac sulfide results in increased expression of ATF3 protein CTD PMID:12734198 more ... sulindac sulfide multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sulindac sulfide results in increased expression of ATF3 mRNA] more ... CTD PMID:16079301 tacrolimus hydrate increases expression ISO RGD:10198 6480464 Tacrolimus results in increased expression of ATF3 mRNA CTD PMID:23958496 tamoxifen multiple interactions EXP 6480464 [Tamoxifen co-treated with ESR2 protein] results in increased expression of ATF3 mRNA CTD PMID:19059307 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of ATF3 mRNA CTD PMID:15604281 tert-butyl hydroperoxide multiple interactions EXP 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ATF3 mRNA more ... CTD PMID:20847119 tert-butyl hydroperoxide decreases expression EXP 6480464 tert-Butylhydroperoxide results in decreased expression of ATF3 mRNA CTD PMID:20196124 tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of ATF3 mRNA CTD PMID:12414654 , PMID:20847119 testosterone multiple interactions EXP 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ATF3 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:10198 6480464 Testosterone results in increased expression of ATF3 mRNA CTD PMID:15788153 testosterone increases expression EXP 6480464 Testosterone results in increased expression of ATF3 mRNA CTD PMID:21592394 tetrachloromethane affects expression ISO RGD:2165 6480464 Carbon Tetrachloride affects the expression of ATF3 mRNA CTD PMID:12734012 tetrachloromethane increases expression ISO RGD:10198 6480464 Carbon Tetrachloride results in increased expression of ATF3 mRNA CTD PMID:27339419 tetrachloromethane increases expression ISO RGD:2165 6480464 Carbon Tetrachloride results in increased expression of ATF3 mRNA, Carbon Tetrachloride results in increased expression of ATF3 protein CTD PMID:12629582 , PMID:30723492 thalidomide increases expression EXP 6480464 Thalidomide analog results in increased expression of ATF3 mRNA CTD PMID:20525221 thapsigargin multiple interactions EXP 6480464 ATF3 mutant form promotes the reaction [Thapsigargin results in increased expression of PMAIP1 mRNA] CTD PMID:20022965 thapsigargin increases expression ISO RGD:2165 6480464 Thapsigargin results in increased expression of ATF3 mRNA CTD PMID:22641616 thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of ATF3 mRNA, Thapsigargin results in increased expression of ATF3 protein CTD PMID:17332266 more ... thimerosal increases expression EXP 6480464 Thimerosal results in increased expression of ATF3 mRNA CTD PMID:16870260 thioacetamide increases expression ISO RGD:2165 6480464 Thioacetamide results in increased expression of ATF3 mRNA CTD PMID:23411599 thiram increases expression EXP 6480464 Thiram results in increased expression of ATF3 mRNA CTD PMID:23999411 , PMID:27965148 titanium dioxide decreases expression ISO RGD:2165 6480464 titanium dioxide results in decreased expression of ATF3 mRNA CTD PMID:30012374 topotecan increases expression ISO RGD:2165 6480464 Topotecan results in increased expression of ATF3 mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:2165 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ATF3 mRNA CTD PMID:25729387 torcetrapib increases expression EXP 6480464 torcetrapib results in increased expression of ATF3 mRNA CTD PMID:23228038 trans-isoeugenol increases expression EXP 6480464 isoeugenol results in increased expression of ATF3 mRNA CTD PMID:23999411 triacsin C increases expression EXP 6480464 triacsin C results in increased expression of ATF3 mRNA CTD PMID:16704987 tributylstannane increases expression ISO RGD:2165 6480464 tributyltin results in increased expression of ATF3 mRNA CTD PMID:21683754 Tributyltin oxide increases expression EXP 6480464 bis(tri-n-butyltin)oxide results in increased expression of ATF3 mRNA, bis(tri-n-butyltin)oxide results in increased expression of ATF3 protein CTD PMID:21601586 , PMID:22613032 Tributyltin oxide increases expression ISO RGD:2165 6480464 bis(tri-n-butyltin)oxide results in increased expression of ATF3 mRNA CTD PMID:21601586 Tributyltin oxide increases expression ISO RGD:10198 6480464 bis(tri-n-butyltin)oxide results in increased expression of ATF3 mRNA CTD PMID:21601586 more ... Tributyltin oxide affects localization EXP 6480464 bis(tri-n-butyltin)oxide affects the localization of ATF3 protein CTD PMID:22613032 trichloroethene increases expression ISO RGD:10198 6480464 Trichloroethylene results in increased expression of ATF3 mRNA CTD PMID:25549359 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of ATF3 mRNA CTD PMID:26272509 trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATF3 mRNA CTD PMID:27188386 trimethyltin increases expression ISO RGD:10198 6480464 trimethyltin results in increased expression of ATF3 mRNA CTD PMID:24002884 troglitazone multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [troglitazone results in increased expression of ATF3 mRNA] more ... CTD PMID:16079301 , PMID:20847119 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of ATF3 mRNA CTD PMID:25572481 troglitazone increases expression ISO RGD:10198 6480464 troglitazone results in increased expression of ATF3 mRNA CTD PMID:28973697 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of ATF3 mRNA, troglitazone results in increased expression of ATF3 protein CTD PMID:15897233 , PMID:16079301 tunicamycin increases expression ISO RGD:10198 6480464 Tunicamycin results in increased expression of ATF3 mRNA CTD PMID:17127020 tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of ATF3 mRNA CTD PMID:22935518 , PMID:29453283 undecanal increases expression EXP 6480464 undecanal analog results in increased expression of ATF3 mRNA CTD PMID:27965148 undecane increases expression ISO RGD:2165 6480464 undecane results in increased expression of ATF3 protein CTD PMID:17337753 urethane increases expression EXP 6480464 Urethane results in increased expression of ATF3 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:10198 6480464 Valproic Acid affects the expression of ATF3 mRNA CTD PMID:17292431 , PMID:17963808 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of ATF3 mRNA CTD PMID:25979313 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of ATF3 mRNA CTD PMID:23179753 more ... vinclozolin increases expression ISO RGD:2165 6480464 vinclozolin results in increased expression of ATF3 mRNA CTD PMID:23034163 , PMID:30207508 vincristine increases expression EXP 6480464 Vincristine results in increased expression of ATF3 mRNA CTD PMID:23649840 vitamin E decreases expression EXP 6480464 Vitamin E results in decreased expression of ATF3 mRNA CTD PMID:19244175 vorinostat increases expression EXP 6480464 vorinostat results in increased expression of ATF3 mRNA CTD PMID:26272509 zidovudine multiple interactions EXP 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of ATF3 mRNA CTD PMID:15784690 zinc acetate multiple interactions EXP 6480464 motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of ATF3 mRNA] CTD PMID:16357179 zinc acetate increases expression EXP 6480464 Zinc Acetate results in increased expression of ATF3 mRNA CTD PMID:16357179 zinc atom multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of ATF3 mRNA CTD PMID:18593933 zinc(0) multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of ATF3 mRNA CTD PMID:18593933
Gene-Chemical Interaction Annotations
